Bath & Body Works (NYSE: BBWI) reported results for its fiscal third quarter ended October 31, 2026, before the market opened on November 19, 2026. The report marks roughly one year into the company's "Consumer First Formula" turnaround strategy, giving investors a progress check on efforts to reignite the brand through product innovation, digital improvements, and expanded distribution through Amazon and Ulta Beauty. The results also set the tone heading into the critical holiday selling season, which typically accounts for a meaningful share of the retailer's annual profit. With comparable-store sales still under pressure, the print offered an important read on whether newer growth channels can offset softness in the company's core North American store base. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Bath & Body Works posted net sales of $1.577 billion for the third quarter of 2026, a 1.0% decline from $1.594 billion a year earlier but ahead of its guidance for a decline of 5.0% to 2.5% and above the consensus estimate of about $1.55 billion. Reported diluted EPS was $0.19, down from $0.37, while adjusted diluted EPS was $0.26, compared with $0.35 in the prior-year period. Net income fell to $38 million from $77 million, and operating income declined to $108 million from $161 million.
Channel performance was mixed. U.S. and Canada store sales decreased 4.3% to $1.169 billion, while direct (online) sales rose 2.6% to $307 million and international and other sales jumped 39.3% to $101 million, reflecting franchise royalties and growing wholesale activity. Management updated its full-year outlook, raising net sales guidance to a decline of 2.1%–3.4%, and set fourth-quarter sales guidance for a decline of 2.0%–5.5% with EPS of $1.41–$1.61. The company also authorized a new $500 million buyback. From what I see, the mixed channel results highlight where the turnaround is gaining traction.
The market's response reflected a split between a better-than-feared quarter and a cautious holiday guide. While the top-line beat and raised full-year sales outlook were positives, fourth-quarter earnings guidance of $1.41–$1.61 per share came in below the roughly $1.73 analysts had modeled, and shares slipped following the report. Investors appeared to weigh the progress in digital, wholesale, and international channels against persistent softness in the core store base and rising cost pressures from tariffs and higher input costs. The new $500 million repurchase authorization offered some support, signaling management's confidence in cash generation even as it takes a measured view of the consumer environment. I’m watching this closely as the buyback adds a layer of support.
Looking ahead, the holiday quarter will be the next major test. Management pointed to a pressured consumer and guided fourth-quarter sales to decline 2.0%–5.5%, with gross margin facing more than 200 basis points of headwind from new tariffs and higher crude oil-linked input costs.
Investors will want to watch whether digital growth, which has now been positive for two consecutive quarters, and the expanding Amazon and Ulta partnerships can continue offsetting weakness in North American stores. Ulta's assortment is set to broaden to roughly 1,500 locations for the holiday period, a notable step up from about 600.
Other items to monitor include the trajectory of gross margin, the pace of savings from the "Fuel for Growth" program, and whether new product franchises such as Essentials and Everyday Luxuries sustain traction into 2027. Management has signaled it does not expect a return to sustainable growth until next year, so evidence that the turnaround is broadening beyond early digital wins will be central to the story.
In my analysis of names like BBWI, I regularly use Tickeron’s AI Screener to filter for comparable retail setups and emerging opportunities. The tool lets me quickly scan technical patterns, fundamentals, and AI signals across the consumer discretionary sector, helping surface ideas that complement traditional earnings reviews without replacing them. It fits naturally into my process for staying on top of turnaround stories and sector peers.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BBWI moved below its 50-day moving average on November 17, 2026 date and that indicates a change from an upward trend to a downward trend. In 33 of 40 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 82%.
The 10-day RSI Indicator for BBWI moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 20 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.
The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BBWI as a result. In 67 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for BBWI turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 39 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBWI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day moving average for BBWI crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 65%.
Following a +4.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where BBWI advanced for three days, in 193 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
BBWI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 91 of 145 cases where BBWI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-4.079) is normal, around the industry mean (2.289). P/E Ratio (5.606) is within average values for comparable stocks, (17.578). Projected Growth (PEG Ratio) (0.658) is also within normal values, averaging (1.159). Dividend Yield (0.037) settles around the average of (0.102) among similar stocks. P/S Ratio (0.472) is also within normal values, averaging (1.057).
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. BBWI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BBWI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of retail business
Industry SpecialtyStores